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Abstract. Endothelial 1 (El) is identified as an en-
dothelial cell secreted factor that stimulates collagen
gel contraction by fibroblasts. This identification is
based on (a) co-localization of stimulatory activity in
endothelial cell conditioned media with synthetic El in
reversed phase analysis; (b) removal of the activity
from conditioned media with antiserum directed
against El; and (c) the activity of synthetic El. Treat-
ment of endothelial cell conditioned media with im-
mobilized anti-El antibodies removed 59% of the ac-
tivity from the pool suggesting that El is the major
contraction promoter in endothelial cell conditioned
F
IBROBLASTS incubated on gels formed of native type I
collagen develop a morphology typical of cells in
dermis and tendon (7, 31) . Additionally, over time the
fibroblasts will reorganize the collagen fibrils into a structure
which closely resembles dense connective tissue (2). Colla-
gen matrices, condensed in this fashion, have been success-
fully transplanted and integrated as dermal replacements
(15). This in vitro phenomenon resembles a number of path-
ologic as well as normal processes including dermal and ten-
donous contracture during wound healing (2), the develop-
ment of contractile connective tissue membranes above and
below the retina in proliferative vitreoretinopathy (19), and
the matrix reorganization observed during connective tissue
development (29) .
Collagen gel contraction by fibroblasts involves the actin
cytoskeleton and can be inhibited by agents such as
cytochalasins (28, 11) . It can involve cell surface integrin-
type receptors since an antibody to the beta-1 subunit can in-
hibit this process when stimulated by PDGF (14) . Gel con-
traction is not dependent upon de novo synthesis of collagens
and apparently does not require enzymatic cross-linking,
degradation or other covalent modifications of the collagens
(11). Heparin can modulate the contraction process by alter-
ing the tensile strength or continuity of the collagen matrix,
though this effect is on the matrix rather than the cells (12).
Gel contraction is dependent upon the presence of exogenous
factors that stimulate cells to exert contractile forces on the
matrix.
We have examined fibroblast-collagen interactions with
the aim ofdefining the exogenous factors that stimulate colla-
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medium. The mechanism of action of El is shown to
be different from serum in that El-promoted contrac-
tion is dependent upon the synthesis of an unknown
effector protein . Synthetic El is shown to be a potent
promoter of gel contraction with half-maximal activity
occurring at 32 pM . Two other endothelins, E2 and
VIC, are slightly less active than El. A fourth en-
dothelin species, E3, is substantially less active. A
comparison of El with other contraction promoting
peptides revealed that El and platelet-derived growth
factor are essentially equal in specific activity,
whereas TGFO is N50-fold more potent.
gen gel contraction by fibroblasts and other nonmuscle cells.
Serum, for example, stimulates matrix contraction by
fibroblasts, but the molecular identities of the active species
are not yet known (28) . The secretory products of en-
dothelial cells, collected as conditioned medium, contain
potent promoters of gel contraction which, as a pool, are
more than 50-fold more potent than serum and act through
mechanisms different from that of serum (13). Type A
promoters, serum derived, can directly stimulate the cellsto
contract matrix through a mechanism which does not require
de novo protein synthesis. Type B promoters, such as that de-
scribed within endothelial cell conditioned medium, are not
active in the presence of an inhibitor of protein synthesis
(13) . In this report, we have identifiedthe endothelins as the
major endothelial cell-secreted peptide promoter of collagen
matrix contraction by fibroblasts.
The endothelins are a recently described family ofacidic,
highly homologous peptides initially identified as potent
vasoconstrictors secreted by vascular endothelial cells (32).
Four known members of the endothelin family, El, E2, E3,
and vasoactive intestinal contractor (VIC)', the mature
forms of which are 21 amino acids in length, were subse-
quently found to have many effects on both vascular and non-
vascular tissues and cultured cells including fibroblasts (for
review see reference 27) . El and E2 bind to high affinity
receptors on both murine and human fibroblast cell surfaces
(30, 5), rapidly increasing the intracellular free Cal+ con-
1. Abbreviations used in thispaper: TFA, trifluoroacetate; VIC, vasoactive
intestinal contractor.
873centration (30, 23), stimulating phospholipase C (30, 22),
and protein kinase C activities (30, 22) in a dose-dependent
fashion . E3 binding to fibroblasts is negligible (23) . The en-
dothelins appear to elicit little mitotic response alone, but
they act synergistically to amplify fibroblast responses to
growth factors such as PDGF, basic fibroblast growth factor,
and insulin-like growth factor-I (17, 3, 30) . These observa-
tions lead us to speculate that the endothelins may serve as
peptide hormones mediating communication between en-
dothelial cells and local fibroblasts and function to amplify
fibroblast growth and to promote matrix contraction by
fibroblasts .
MaterialsandMethods
Cells
Culturesofhumanskin fibroblastswere establishedfrom foreskins obtained
at circumcisions and used between passages 4 and 15 . Cells were cultured
in 75-cm2 tissue culture flasks using growth medium composed of DME,
20 mM Hepes, and 10% FBS all from Gibco Laboratories (Grand Island,
NY) (13) . The cultures were incubated in an humidified atmosphere con-
taining 5% C02 and 95% air. Cells were harvested for subculture or ex-
perimentation using 0.5% trypsin/0.02% EDTA solution (Gibco Laborato-
ries) . Bovine aortic endothelial cells were provided by Dr. Joanne
Murphy-Ullrich (University of Alabama at Birmingham) . These were
grown under conditions similar to the fibroblasts except that the media con-
tained 20% FBS .
Preparation ofEndothelial Cell ConditionedMedium
Endothelial cells were grown to confluence in 75-cm2 tissue culture flasks
inDME with 20% FBS as described previously (13) . At confluence, the
growth medium was removed, the cell monolayers were rinsed and in-
cubated further in serum-free DME . Each day for five days the culture
medium was removed and replaced with fresh serum-freeDME . The collec-
tion from the first day was discarded to exclude potential contamination by
serum . The collected media were centrifuged to remove cell debris and
stored at -20°C until use .
Preparation ofCollagen Gels andMeasurement of
Matrix Contraction by Fibroblasts
Native collagen gels were preparedas described previously (13) using Vitro-
gen 100 (Collagen Corp., Palo Alto, CA) adjusted to physiological ionic
strength and pH with lOx PBS (1,5 M NaCl, 0.1 M Na2HP04) and 0.1 M
NaOH, while maintained at 4°C . Aliquots (0.2 ml) of the collagen solution
were added within circular scores (12 mm) onthe bottom of 24-well culture
plates and polymerized at 37°C for 90 min . The resultant gel thickness was
tit mm .
Fibroblasts harvested as for subculture were washed with growth media
containing serum and again with serum-freeDME before application onto
the top of the polymerized gels (5 x 104 cells/gel in 0.05 ml) . The cultures
were incubated at 37°C for 30 min to allow the cells to attach after which
the wells were flooded with 1 ml DME containing the test substances . In
experiments involving transforming growth factor beta (TGFO), all wells
were flooded with DME containing 1 .0 mg/ml BSA, according to the
manufacturer's instructions. Collagen gel contraction is observed as a func-
tionof changes in gel thickness . These were measured on an inverted phase
contrast microscope (Nikon TMS ; Nikon Inc ., Garden City, NY) by adjust-
ing the plane of focus from the bottom to the top of the gel and recording
the distance ofobjective stage movement with a Z axis digitizer (LaSICO,
Los Angeles, CA) . This method of measurement is reproducible to 25,um
or 1.25% of the initial gel thickness (11) . Photomicrographs of fibroblasts
were taken using an inverted phase contrast microscope equipped with a
lOx objective .
Reversed Phase Fractionation ofEndothelial
Cell ConditionedMedium
The proteins in conditioned medium (50 ml), prepared as described above,
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were concentrated over a 1.0-ml C,g syringe cartridge (Analtech Inc., New-
ark, DE) . The cartridge was washed with 10 ml H2O/0.1% trifluoroacetate
(TFA) and eluted with 10 m160% acetonitrile/H20/0.1% TFA . The eluted
pool was lyophilized, reconstituted with H2O/0.1% TFA, loaded over a
Vydac C,8 analytical column, and eluted at 1 .0 ml/min with a linear gra-
dient of0-60% acetonitrile containing 0.1 % TFA . Eluted proteins were de-
tected at 225 nm . Fractions corresponding to 2min ofelution were collected
in polypropylene tubes . Samples (50 Wl) of each fraction were lyophilized
and reconstituted with 0.1 ml DME containing I mg/ml BSA before assay
for stimulatory activity.
Reagents
Synthetic El, E2, E3, and VIC were obtained from Peninsula Laboratories
Inc . (Belmont, CA) . Rabbit anti-human El antiserum was obtained from
Dr. Eng Tau (Peninsula Laboratories) . This antiserum, raised against syn-
thetic El was reported by the supplier to have 7% cross-reactivity with E2
and E3 . Human TGFg, was purchased from Oncomembrane Inc . (Seattle,
WA) . Human recombinant PDGF-BB homodimer was purchased from Up-
state Biotechnology Inc . (Lake Placid, NY) . All peptides were reconstituted
according to the manufacturers' instructions . Protein A Agarose was pur-
chased from Pierce Chemical Co . (Rockford, IL) . Other reagents were ob-
tained from Sigma Chemical Co . (St . Louis, MO) .
Results
Identification ofEndothelin1 as an Endothelial Cell
SecretedPromoter ofCollagen Gel Contraction
Endothelial cell conditioned media proteins (2 mg in 50 ml)
were fractionated by reversed phase HPLC using a gradient
of 0-60% acetonitrile/0.1% TFA/H20 over 40 min as de-
scribed in Materials and Methods (Figs . 1 A, solid line) .
Fractions (2 .0 ml) corresponding to two minutes were col-
lected . Lyophilized aliquots of each fraction (50 /1) were
reconstituted with 1 ml DME containing 1 mg/ml BSA and
added to cultures of fibroblasts seeded on collagen gels.
These were incubated for 4 h at 37°C after which changes
in gel thickness were recorded (Fig . 1 B) . The two fractions
eluted between minutes 26 and 30 were active in promoting
collagen gel contraction . Electrophoretic analysis of the ac-
tive fractions using 5-15% acrylamide gradient gels did not
reveal peptide(s) whose presence corresponded with the ac-
tivity. There were, however, several small (<14 kD), poorly
resolved bands near the ion front (not shown) . As the molec-
ular masses of the endothelins are in the range of 2 .5kD and
El is known to be synthesized and secreted by endothelial
cells we analyzed the possible relation between El and the
activity we observed in the reversed phase fractions. Syn-
thetic El (3 tig) was loaded and eluted from the same C l ,,
column under the same conditions as the conditioned media
proteins . The elution position of the synthetic peptide cor-
responded to the major contraction-promoting activity of en-
dothelial cell conditioned medium (Fig . 1 A, dotted line) .
Attempts to identify El within endothelial cell conditioned
media by western blotting were unsuccessful . This was pri-
marily because of the difficulties we encountered in resolv-
ing the low molecular weight peptide by gel electrophoresis .
To confirm that the contraction-promoting activity observed
was in fact because of El we attempted to remove the activ-
ity using an antiserum raised against synthetic El . Direct
neutralization of the activity with the antiserum was not pos-
sible given that serum also contains contraction-promoting
factors . It was necessary to first separate the IgG fraction
from the rest of the serum proteins . To accomplish this,
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Figure 1. Reversed phase fractionation of endothelial cell condi-
tioned media proteins. Conditioned medium proteins (-2 .0 mg)
were concentrated over a C,8 cartridge, eluted with 60% acetoni-
trile/0.1% TFA, and lyophilized. This pool was reconstituted with
H2O/0.1% TFA and fractionated by reversed phase HPLC over a
C,8 column using a linear gradient of acetonitrile (0-60%) as de-
scribed in Materials and Methods (A, solidline). 2.0-ml fractions,
corresponding to 2 min, were collected and assayed individually for
contraction-promoting activity on fibroblasts attached to collagen
gels. The extent of contraction observed for 50 j1 of each fraction
after 4 h ofincubation is shown inB. The retention time ofthe active
fractions is compared to the retention time of synthetic El (3 l~g)
eluted under identical conditions (A, dotted line).
50-ul aliquots of protein A agarose were preincubated for
60 min with 50 ul anti-El antiserum or, as a control, nonim-
mune rabbit serum. These affinity matrices were washed
with PBS (3 x 1 ml) and then incubated with 5.0 ml of un-
fractionated endothelial cell conditioned medium for 60 min
at room temperature while mixing. After the incubation the
affinity matrices were removed by centrifugation and the su-
pernatants were tested in dilutions for contraction-promot-
ing activity on fibroblasts attached to collagen gels. The
results of this experiment, shown in Fig. 2, indicate that the
anti-El matrix removed a substantial portion of the contrac-
tion-promoting activity observed after 4 h of incubation. A
second treatment ofthe supernatants with additional anti-El
matrix did not reduce the remaining contraction-promoting
activity further (data not shown).
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Linear regression analysis ofthe data in Fig. 2 yielded the
functions y = 30.09(log x) + 6.80 and y = 33.31(log x)
- 8.22 for nonimmune and immune serum-treated samples,
respectively, with r~oR of 0.993 and 0.991 (Fig. 2, dotted
lines) . Defining one unit of contraction-promoting activity as
the amount necessary to induce fibroblasts to reduce colla-
gen gel thickness by 25 %, we can calculate the activities of
the two pools as 24.80 U/ml for nonimmune serum-treated
and 10.06 U/ml for immune serum-treated media. These cal-
culations indicate that the immunoreactive material accounts
for 59 % of the contraction promoting activity present in en-
dothelial cell conditioned medium.
El Promotes Collagen Gel Contraction byFibroblasts
To demonstrate that El can stimulate collagen gel contrac-
tion we performed a series of experiments using synthetic El
added to serum-freeculture medium. Fibroblasts attached to
collagen gels were incubated in DME containing FBS (posi-
tive control), 1.0 pg/ml El, or DME alone (negative control).
Hourly measurements of gel thickness indicated that the
synthetic El was able to stimulate gel contraction (Fig. 3).
The onset ofEl-promoted contraction, however, was delayed
2-3 h, compared to serum.
Fibroblast morphologies differed only upon the presence
or absence of a contraction promoter. Fibroblasts incubated
in DME alone remained rounded. Only thin cytoplasmic
processes were visible in photomicrographs taken after 2
and 8 h of incubation (Fig. 4, A and D). The morphologies
of fibroblasts incubated in El or serum were not significantly
different at any stage of the assay. The lack of morphological
difference between the serum and El-stimulated cells were
particularly remarkable given the large differences in colla-
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Figure 2. Immunoprecipitation of El from endothelial cell condi-
tioned medium. 5-ml aliquots of endothelial cell conditioned me-
dium were incubated for 60 min at room temperature with 50 tcl
protein A Sepharose preloaded with 50 pl rabbit anti-El serum(e)
or 50 ,al nonimmune rabbit serum (o). After incubationthe affinity
beads were pelleted by centrifugation and the supernatants were
tested at the indicated dilutions for contraction-promoting activity
on fibroblasts seeded onto collagen gels. The data shown for each
concentration are the means and ranges of results from duplicate
cultures after 4 h of incubation. The dotted lines are plots of the
functions derived from linear regression analysis of the data.
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Figure 3. Fibroblast contraction is promoted by El. Fibroblasts
seeded onto collagen gels were incubated at 37°C in DME alone
(o), DME with 1.0 pglml of El (o), or 1.0 mg/ml FBS (0). At the
times indicated, gel thickness was measured. The data shown are
the means and standard deviations of results from triplicate cul-
tures. Other details are described in Materials and Methods.
gen gel thickness at the timesphotographed. After two hours
of incubation, El-stimulated cells (Fig. 4 B) had not yet re-
duced the gel thickness, but exhibited cytoplasmic spreading
and extended large processes. These features, normally as-
sociated with fibroblasts actively contracting collagen were
also visible in serum-stimulated fibroblasts, which had re-
duced the thickness of the matrices by greater than 40% dur-
ing the same period (Fig. 4 C) . The lack of morphological
difference between the differentially stimulated cells per-
sisted and was evident for both El (Fig. 4 E) and serum (Fig.
4 F) stimulated cells after 8 h of incubation when El-
stimulated contraction was more pronounced (45 %).
Experiments were performed to measure the potency of El
in stimulating collagen gel contraction by fibroblasts. Fibro-
blasts attached to collagen gels were incubated in DME con-
taining El at concentrations ranging from 4 x 10-6-4 x
10-'° M . The resulting collagen gel thicknesses were mea-
sured after 10 h of incubation (Fig. 5) . The extent of matrix
contraction remained essentially constant from the highest
dose down to 4 .0 x 10-'° M after which the activity rapidly
decreased. The El concentration which would result in 25
reduction in gel thickness (approximately half-maximal) was
calculated from a linear regression analysis of the data in
Fig. 5, as 3.2 x 10-" M. This is comparable to other
reports of endothelin-induced effects on fibroblasts in vitro
(30, 3) .
El IsA TypeB Contraction Promoter
To investigate if El-promoted contraction required de novo
protein synthesis, fibroblasts were seeded onto collagen gels
and incubated in DME with 4 nM El or FBS, with or without
25 pg/ml cycloheximide. This concentration of cyclohexi-
mide was found to inhibit incorporation of 3s[Slmethionine
by >95 % without decreasing cell viability (data not shown) .
At varying times during the incubation gel thickness was
measured (Fig. 6 A) . FBS-promoted gel contraction was es-
sentially unaffected by the addition of cycloheximide, which
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was consistent with our previous observations (13) . There
was, however, a substantial effect on El-promoted contrac-
tion. El stimulation of cycloheximide-blocked fibroblasts
resulted in only 5% reduction in gel thickness during 8 h of
incubation. Gels containing nonblocked cells were reduced
in thickness by 45% during the same period .
To assess what effect removal ofEl would have on gel con-
traction, fibroblasts were seeded onto collagen gels and in-
cubated in DME containing 4 nM El (Fig. 6 B, e) . After
each hour the media from triplicate wells were removed and
replaced with fresh serum-free DME and incubated further
(Fig. 6 B, o) . The rate of gel contraction was not signifi-
cantly reduced by removal ofthe peptide indicating that after
the initial exposure, El is no longer required.
Together, these two experiments indicate that El-promoted
gel contraction is via an effector protein. Additionally, it ap-
pears that El is a type B contraction promoter with charac-
teristics similar to that observed previously with unfractio-
nated endothelial cell conditioned medium (13).
Comparison ofEl ActivitywithOther
KnownEndothelins
While there is considerable sequence homology among the
different endothelins, there are differences in the target
receptors and distributions of the different peptides (23, 5).
These observations suggest potential differences in the bio-
logical activities of the different endothelins. For these rea-
sons it was of interest to examine the potential contraction
promoting activities of the other endothelins. Fibroblasts at-
tached to collagen gels were incubated in DME containing
0.4,uM El, E2, E3, or VIC. Hourly measurements of gel
thickness revealed that, at this concentration, all of the en-
dothelins were active in promoting gel contraction (Fig. 7
A). El, E2, and VIC were essentially identical in both rate
and extent of contraction observed. E3, however, appeared
to be less active than the other three species.
Experiments to measure the potencies of the different en-
dothelins were performed in a manner similar to that de-
scribed in the legend to Fig. 5. However, because of the large
numbers of samples required for these experiments it was
necessary to test each peptide separately. To facilitate direct
comparison the results from each experiment were normal-
ized to internal positive controls (FBS) by dividing the
peptide-promoted responses by the serum-promoted re-
sponse. The results of these assays, all taken after 10 h of
incubation indicate that E2 and VIC are also active at
picomolar concentrations (Fig. 7 B). E3 was active only at
the highest concentration tested.
Comparison ofEndothelinpromoted Gel
Contraction withPDGFand TGFg
Two growth factors which have been reported to promote col-
lagen gel contraction by fibroblasts are transforming growth
factor beta (TGF#) (21) and PDGF (1, 4, 14). Previously we
reported that the extent of TGFß-stimulated gel contraction
was <10% during 4 h of incubation (13). Because El-stim-
ulated gel contraction required longer incubations we again
examined the stimulatory activity of TGFp using incubations
of up to 10 h. El was also compared to PDGF-BB, the form
determined to be the most active in stimulating gel contrac-
tion (4). Fibroblasts placed on top of collagen gels were
876Figure 4. Morphology of fibroblasts contracting collagen . Phase-contrast micrographs ofcells incubated as described in the legend to Fig . 3
after 2 (A, B, and C) and 8 (D, Eand F) h of incubation in DME alone (A and D), El (B and E), or FBS (C and F) . Other details are
described in Materials and Methods. Bar, 100 um .
incubated in DME-BSA (1 mg/ml) containing 4 nM El,
TGF# ,, or PDGF-BB, and incubated at 37°C . Hourly mea-
surements of gel thickness indicate that of the three factors,
gel contraction promoted by PDGF-BB had the most rapid
onset (Fig. 8 A) . The onset ofTGFß l-promoted gel contrac-
tion was the most delayed among the three.
The potencies of each promoter were examined by in-
cubating fibroblasts in varying concentrations of each pro-
moter. The results of these assays, normalized to internal
controls as in Fig . 7 B, suggest that El and PDGF-BB are
of essentially equal potency (Fig . 8 B) . TGF0 , appears to
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be considerably more active. Activity calculations from lin-
ear regression analyses yield 25% contraction-promoting
doses of 26.9 pM for PDGF-BB and 0.51 pM for TGFO ,,
respectively, compared to 32 pM for El .
Discussion
We have identified El as an endothelial cell secreted factor
that stimulates collagen gel contraction by fibroblasts . This
was accomplished by : (a) colocalization of synthetic El with
the contraction-promoting activity ofendothelial cell condi-
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Figure S. Dose response of El-promoted fibroblast contraction. Fi-
broblasts seeded onto collagen gels were incubated at 37°C inDME
containing El (O) at the indicated concentrations. After 10 h of in-
cubation, gel thickness was measured. The data presented are the
average and range of results obtained from duplicate cultures at
each concentration. Other details are described in Materials and
Methods.
tioned medium in reversed phase analysis; (b) removal of
contraction-promoting activity from conditioned medium
with antiserum raised against synthetic El; and (c) demon-
stration of contraction-promoting activity with synthetic El.
Analysis ofthe data from the anti-El treated and control con-
ditioned media samples indicated that removal of El de-
creased the contraction-promoting activity of the media by
59% . From this we conclude that El is the major contrac-
tion-promoting factor in the conditioned medium pool.
Dose response analysis of El-stimulated contraction indi-
cated that El is active at picomolar concentrations with half-
maximal effect (25% reduction in gel thickness) occurring
at -32 pM. Similar studies performed with three other en-
dothelins indicate that the different species are not equal in
stimulatory activity. E2 and VIC were observed to be
slightly less active than El. E3, however, was approximately
four orders of magnitude less active than El. These data are
in agreement with studies ofthe relative affinities of the vari-
ous endothelins for fibroblast receptors (23, 5).
Experiments to characterize El-stimulated contraction
suggest that mechanistically it is a type B promoter. Type A
promoters (FBS derived) stimulate contraction directly in
contrast to type B promoters which require synthesis of an
effector protein (13). El stimulation was observed to be de-
pendent upon de novo protein synthesis and continued after
removal of the promoter.
Finally, El-promoted contraction was compared with that
of two growth factors, PDGF (1, 4, 14), and TGFO (21, 25),
each of which is reported to stimulate matrix contraction by
fibroblasts. These experiments demonstrated that the spe-
cific activities of El and the most active isomer of platelet-
derived growth factor (PDGF-BB), were essentially equal.
Half-maximal contraction (25 %) was calculated to occur at
a concentration of 26.9 pM PDGF-BB. TGF#, was found to
be -50-fold more active with half-maximal contraction cal-
culated to occur at 0.51 pM.
These results are somewhat different from those obtained
The Journal of Cell Biology, Volume 115, 1991
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Figure 6. Characterization of El as a type B promoter. (A) Fibro-
blasts seededontocollagen gels were incubated in DME containing
1.0 mg/ml FBS (o,e) or 4 nM El (o,w) with (closed symbols) or
without (opensymbols) 25 Ag/ml cycloheximide with triplicate cul-
tures under each condition. At the times indicated, gel thickness
was measured. (B) Fibroblasts seeded onto collagen gels were in-
cubated in DME alone (m) or containing 4 nM El (9). At hours
1, 2, and 3 the media in triplicate cultures were exchanged for fresh
serum free DME without additives (o) and the incubation con-
tinued. At the times indicated gel thickness was measured.
by other investigators. Clark and co-workers observed little
or no collagen gel contraction by TGFß-stimulated fibro-
blasts during the first 24 h of incubation (4) . While we have
also observed a significant delay in the onset of TGFß-
stimulated gel contraction, substantial changes in gel thick-
ness were observed after 6 h of incubation. The reasons for
.these differences are unclear. Our assay system is different
in that the cells are placed on the top of the gel rather than
polymerized within the gel. However, an earlier study re-
vealed that cells in both locations are equally contractile
(10) . Other differences include cell numbers, collagen con-
centrations as well as method to measure gel contraction.
The delays in onset of El, as well as TGFs and PDGF,
promoted gel contraction are somewhat confusing. While
the fibroblasts do develop a contractile morphology rela-
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Figure 7. Fibroblast contraction is differentially promoted by the
various endothelins. (A) Fibroblasts seeded onto collagen gels were
incubated at 37°C in DME alone (A) or containing 0.4,uM El (e),
E2 (o), E3 (m), VIC (o), or 1.0 mg/ml FBS (o) At the times indi-
cated gel thickness was measured. (B) In separate assays, fibro-
blasts seeded onto collagen gels were incubated at 37°C in DME
containing El (o), E2 (m), E3 (o), or VIC (9) at the indicated
concentrations. After 10 h of incubation gel thickness was mea-
sured. The data shown are the mean and range of results obtained
fromtriplicate cultures in A and duplicate cultures in B at each con-
centration tested. For direct comparisonthe data from each experi-
ment in B were normalized by dividing the peptide-promoted re-
sponse by the serum-promoted internal standard from each assay.
tively soon after exposure to El, the onset of measurable
contraction is delayed by 2-3 h. This can be contrasted with
fibroblasts treated with either serum or complete endothelial
cell conditioned medium in which substantial contraction is
measurable within the first hour of exposure (13) . These ob-
servations are particularly surprising in that other studies of
endothelin-induced effects on fibroblasts demonstrate sec-
ond messenger effects, such as protein kinase C and phos-
pholipase activation within minutes of exposure (30, 22) .
Also, anti-El-treated endothelial cell conditioned medium
was diminished in contraction-promoting activity measur-
able within the first hour (data not shown) . These observa-
tions lead us to suggest that El in conditioned medium acts
Guidry and Hook Endothelins Stimulate Fibroblast Contraction of Collagen
v
0
N
E
0
Z
c
O
0
w r
C
0
0
be
879
60
50
c
O
:- 40
u
40
.`- 30 c
80
60
40
20
0
0 1 2 3 4 5 6
Hours
10-1e 10-14 10-12 10-10 10-6
Peptide Molarity
Figure 8. Kinetics and dose response for fibroblast contraction
promoted by El, PDGF-BB, and TGF%. (A) Fibroblasts seeded
onto collagen gels were incubated in DME + BSA alone (o), with
0.2 nM El (o) PDGF-BB (o), TGFm (m), or 1.0 mg/ml FBS (o) .
At the times indicated gel thickness was measured . The data shown
are the means and standard deviations ofresults from triplicate cul-
tures. (B) In separate assays, fibroblasts seeded onto collagen gels
were incubated at 37°C in DME + BSA containing El (9), PDGF-
BB (o) or TGFO, (n) as described in the legend to Fig. 7. The nor-
malized data are the mean and range ofresults obtained from dupli-
cate cultures at each concentration.
with or as a co-factor to other peptide promoters. In support
ofthis notion are other studies demonstrating mitogenic syn-
ergism between El and several growth factors (30, 17, 3) . It
is possible that TGFO, or other promoters, might act syner-
gistically with El to produce the rapid onset matrix contrac-
tion we have observed with both serum and endothelial
cell-conditioned medium stimulated fibroblasts.
Another question raised by these studies concems the sec-
ond messengers involved in promoting fibroblast contractile
activity. The second messengers activated by endothelins
during the first hour of exposure, protein kinase C, phos-
pholipase C (30, 22), are obviously not sufficient to produce
the relatively rapid contractile response observed with either
serum or endothelial cell conditioned medium (13). Potentialexplanations are that contraction requires activation ofdiffer-
ent second messengers, or perhaps even multiple systems.
While the activation resulting in fibroblast contraction does
eventually occur with endothelins, PDGF and TGFO, it ap-
pears to be a secondary rather than primary effect of the
peptides.
The physiological significance of these observations is not
yet clear. The endothelins were identified and character-
ized mainly as vasoactive peptides which are potent in
promoting extremely rapid short-lived alterations in vascular
tone, presumably through their effects on vascular smooth
muscle (32) . Studies in which embryonic and adult tissues
were probed with radiolabeled El to identify receptors did
not localize receptors within connective tissues (18, 16) .
This, however, is inconsistent with the observations that, in
vitro, fibroblasts as well as a number of other nonvascular
cells, are sensitive to endothelin stimulation. An attractive
hypothesis is that quiescent fibroblasts in tissues do not nor-
mally express endothelin receptors, but do so during wound
healing.
A number of recent studies serve to illustrate' both the
complexity of the wound environmentas well as provide rea-
son for caution in overinterpreting data from simplified in
vitro models. Fibroblasts isolated from granulation tissue
have greater sensitivity to TGFp than fibroblasts isolated
from normal skin, suggesting that there are significant
phenotypic differences in cells isolated from normal versus
nonwounded skin (8) . Several studies of wound exudates
have determined the presence of factors which promote (20)
as well as prevent matrix contraction by fibroblasts (6, 26).
Two different growth factors which promote matrix contrac-
tion by fibroblasts in vitro (PDGF and TGFO) have different
effects when applied directly to developing granulation tis-
sue (24) . Continued exploration of the mechanisms of these
regulatory factors at the molecular level should provide in-
sights into their roles in wound repair.
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